Brevundimonas diminuta Bacteremia in a Case of Adrenal Insufficiency: A Case Report and Literature Review
Abstract
Brevundimonas diminuta is an uncommon Gram-negative bacteria rarely isolated from clinical samples. There are few reports of infections caused by this microorganism, especially in immunocompromised patients. We present a case of a 69-year-old male with a history of adrenal insufficiency who presented with B. diminuta bacteremia. The patient's immunocompromised state, resulting from chronic corticosteroid use, likely predisposed him to this rare infection. The limited number of reported cases highlights the need for awareness of this pathogen, especially in vulnerable populations. To the best of our knowledge, this is the first case report of a B. diminuta infection in a patient with bacteremia in the setting of adrenal insufficiency in the United States.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.